Atara Biotherapeutics Ownership | Who Owns Atara Biotherapeutics?
Atara Biotherapeutics Ownership Summary
Atara Biotherapeutics is owned by 22.36% insiders, and 77.64% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.09% of its assets in Atara Biotherapeutics shares.
ATRA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Atara Biotherapeutics | - | 22.36% | 77.64% |
Sector | Healthcare Stocks | 57.43% | 9.41% | 33.16% |
Industry | Biotech Stocks | 69.02% | 8.92% | 22.06% |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 2 | 100.00% | 63 | 80.00% | - | 360000.00% | 1 | - | - | - |
Sep 30, 2024 | 1 | -80.00% | 35 | -99.98% | - | 2.78% | - | -100.00% | - | -100.00% |
Jun 30, 2024 | 5 | -93.98% | 182,077 | -99.78% | - | 0.00% | 1 | -97.62% | 2 | -92.86% |
Mar 31, 2024 | 83 | -9.78% | 83,283,248 | 28.68% | 78 | 2.13% | 42 | -8.70% | 28 | -15.15% |
Dec 31, 2023 | 92 | -19.30% | 64,720,313 | -26.10% | 60 | 0.88% | 46 | -11.54% | 33 | -10.81% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 120.26K | 2.09% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 66.25K | 1.15% | 11.78K |
Fidelity Extended Market Index | 29.96K | 0.52% | 4.85K |
Bridgeway Ultra-Small Company Market | 14.00K | 0.24% | - |
Fidelity Enhanced Small Cap ETF | 10.45K | 0.18% | - |
NT R2000 Value Index Fund - NL | 255.47K | 0.18% | - |
NT R2000 Index Fund - NL | 9.83K | 0.17% | -1.01K |
Fidelity VIP Disciplined Small Cap Init | 9.63K | 0.17% | - |
Fidelity Total Market Index | 8.13K | 0.14% | - |
NT R2000 Index Fund - DC - NL - 2 | 7.78K | 0.14% | -834.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 03, 2025 | Nguyen AnhCo | President and CEO | Sell | $23.31K |
Mar 03, 2025 | Hyllengren Eric J | EVP, CFO and COO | Sell | $8.47K |
Mar 03, 2025 | Henrich Jill | EVP, Chief Regulatory Officer | Sell | $7.41K |
Nov 18, 2024 | Henrich Jill | EVP, Chief Regulatory Officer | Sell | $11.20K |
Nov 18, 2024 | Hyllengren Eric J | EVP, CFO and COO | Sell | $15.27K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 3 |
2024 Q4 | - | 3 |
2024 Q3 | - | 12 |
2024 Q2 | - | 5 |
2024 Q1 | - | 6 |
ATRA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools